Clinical trial
The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
NCT02748408 is registered in ClinicalTrials.gov with Medacta International SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
- Lead sponsor
- Medacta International SA
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 31, 2015
- Completion date
- July 31, 2032
- Enrollment
- 550 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
arthrosis, avascular necrosis of the femoral head, congenital hip dysplasia, rheumatoid polyarthritis, traumatic arthritis